R-Pharm Group to launch Glatirat
Posted: Tue May 31, 2016 4:29 am
The Russian Ministry of Health has granted Marketing Authorisation to R-Pharm JSC for the development of Glatirat, a drug intended for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS) and clinically isolated syndrome...Read more - http://www.ms-uk.org/MSnews